In comparison to normal PBMCs, WT1 mRNA was detected at higher levels in all 18 patients with acute leukemia (AML), including 3 patients with acute lymphoblastic leukemia (ALL) and 15 patients with acute myeloid leukemia (AML). This evidence concerns the gene WT1 and acute lymphoblastic leukemia.